Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lassa Fever | 30 | 2024 | 97 | 7.880 |
Why?
|
Antimalarials | 60 | 2023 | 903 | 7.030 |
Why?
|
Malaria, Falciparum | 55 | 2023 | 1071 | 6.660 |
Why?
|
Artemisinins | 37 | 2020 | 222 | 6.260 |
Why?
|
Nigeria | 79 | 2024 | 731 | 6.070 |
Why?
|
Amodiaquine | 32 | 2023 | 62 | 5.640 |
Why?
|
Lassa virus | 26 | 2024 | 97 | 5.420 |
Why?
|
Plasmodium falciparum | 42 | 2022 | 1726 | 4.690 |
Why?
|
Fluorenes | 18 | 2023 | 159 | 2.420 |
Why?
|
Ethanolamines | 18 | 2023 | 158 | 2.240 |
Why?
|
Ebolavirus | 13 | 2020 | 263 | 2.090 |
Why?
|
Genome, Viral | 11 | 2024 | 667 | 2.000 |
Why?
|
Drug Resistance | 20 | 2021 | 1608 | 1.920 |
Why?
|
Parasitemia | 19 | 2019 | 174 | 1.890 |
Why?
|
Hemorrhagic Fever, Ebola | 14 | 2020 | 428 | 1.770 |
Why?
|
Chiroptera | 2 | 2024 | 107 | 1.740 |
Why?
|
Protozoan Proteins | 11 | 2021 | 827 | 1.560 |
Why?
|
Disease Outbreaks | 16 | 2022 | 1768 | 1.380 |
Why?
|
Drug Combinations | 30 | 2023 | 1961 | 1.090 |
Why?
|
Monkeypox virus | 3 | 2023 | 48 | 1.070 |
Why?
|
Anemia | 14 | 2019 | 1499 | 1.060 |
Why?
|
Dihydropteroate Synthase | 2 | 2021 | 27 | 1.050 |
Why?
|
Chloroquine | 9 | 2015 | 280 | 1.040 |
Why?
|
Multidrug Resistance-Associated Proteins | 4 | 2020 | 106 | 1.010 |
Why?
|
RNA, Viral | 9 | 2023 | 2899 | 1.000 |
Why?
|
Tetrahydrofolate Dehydrogenase | 2 | 2021 | 143 | 1.000 |
Why?
|
Phylogeny | 12 | 2024 | 2797 | 0.940 |
Why?
|
Antigens, Viral | 9 | 2020 | 1034 | 0.940 |
Why?
|
Malaria | 10 | 2024 | 1232 | 0.930 |
Why?
|
Nucleoproteins | 3 | 2020 | 115 | 0.900 |
Why?
|
RNA Viruses | 2 | 2022 | 124 | 0.890 |
Why?
|
Insect Viruses | 1 | 2022 | 15 | 0.870 |
Why?
|
Arboviruses | 1 | 2022 | 12 | 0.860 |
Why?
|
Abattoirs | 1 | 2021 | 5 | 0.820 |
Why?
|
Hemorrhagic Disease Virus, Rabbit | 1 | 2021 | 2 | 0.820 |
Why?
|
Dengue Virus | 1 | 2024 | 204 | 0.820 |
Why?
|
Polymorphism, Genetic | 8 | 2021 | 4328 | 0.810 |
Why?
|
Caliciviridae Infections | 1 | 2021 | 29 | 0.800 |
Why?
|
Shiga-Toxigenic Escherichia coli | 1 | 2021 | 28 | 0.790 |
Why?
|
Aedes | 1 | 2022 | 100 | 0.790 |
Why?
|
Food Microbiology | 1 | 2021 | 78 | 0.790 |
Why?
|
Pyrimethamine | 7 | 2021 | 98 | 0.790 |
Why?
|
Antibodies, Viral | 11 | 2020 | 3164 | 0.770 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2021 | 92 | 0.760 |
Why?
|
Coronavirus | 1 | 2023 | 158 | 0.760 |
Why?
|
HIV Integrase | 1 | 2022 | 120 | 0.750 |
Why?
|
Dengue | 1 | 2024 | 256 | 0.750 |
Why?
|
Membrane Transport Proteins | 6 | 2020 | 1028 | 0.740 |
Why?
|
Sulfadoxine | 5 | 2021 | 50 | 0.720 |
Why?
|
Food Contamination | 1 | 2021 | 189 | 0.720 |
Why?
|
HIV Integrase Inhibitors | 1 | 2022 | 142 | 0.720 |
Why?
|
Metagenome | 2 | 2020 | 417 | 0.700 |
Why?
|
Yellow Fever | 1 | 2020 | 53 | 0.700 |
Why?
|
Viruses | 1 | 2023 | 374 | 0.700 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 800 | 0.660 |
Why?
|
Epidemics | 2 | 2022 | 521 | 0.640 |
Why?
|
Computer Systems | 1 | 2020 | 483 | 0.640 |
Why?
|
Africa, Western | 10 | 2023 | 154 | 0.630 |
Why?
|
Meat | 1 | 2021 | 595 | 0.630 |
Why?
|
Genes, MDR | 2 | 2008 | 37 | 0.630 |
Why?
|
Child, Preschool | 55 | 2021 | 40955 | 0.620 |
Why?
|
Zoonoses | 5 | 2023 | 184 | 0.590 |
Why?
|
Sex Ratio | 7 | 2011 | 110 | 0.570 |
Why?
|
Genomics | 12 | 2023 | 5692 | 0.550 |
Why?
|
Infant | 44 | 2021 | 35070 | 0.540 |
Why?
|
Rhabdoviridae | 1 | 2015 | 5 | 0.530 |
Why?
|
Rhabdoviridae Infections | 1 | 2015 | 8 | 0.530 |
Why?
|
Disaster Planning | 1 | 2021 | 549 | 0.520 |
Why?
|
Hematocrit | 10 | 2019 | 636 | 0.510 |
Why?
|
Staphylococcal Infections | 1 | 2024 | 1398 | 0.500 |
Why?
|
Rabbits | 1 | 2021 | 4886 | 0.500 |
Why?
|
Polymerase Chain Reaction | 10 | 2021 | 6171 | 0.480 |
Why?
|
Haplotypes | 7 | 2021 | 2781 | 0.460 |
Why?
|
Metagenomics | 3 | 2023 | 430 | 0.460 |
Why?
|
Hepatitis B | 3 | 2023 | 695 | 0.460 |
Why?
|
Child | 55 | 2023 | 77478 | 0.460 |
Why?
|
Humans | 135 | 2024 | 742088 | 0.440 |
Why?
|
Genetic Variation | 10 | 2021 | 6540 | 0.430 |
Why?
|
Pandemics | 9 | 2024 | 8328 | 0.400 |
Why?
|
Drug Therapy, Combination | 22 | 2021 | 6483 | 0.390 |
Why?
|
DNA, Protozoan | 5 | 2012 | 237 | 0.380 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1825 | 0.370 |
Why?
|
Africa | 7 | 2022 | 670 | 0.370 |
Why?
|
Animals | 46 | 2024 | 168561 | 0.360 |
Why?
|
Mutation, Missense | 2 | 2011 | 2556 | 0.350 |
Why?
|
Linkage Disequilibrium | 3 | 2021 | 1995 | 0.350 |
Why?
|
Selection, Genetic | 4 | 2014 | 914 | 0.350 |
Why?
|
Hepatitis B, Chronic | 2 | 2023 | 393 | 0.340 |
Why?
|
Mefloquine | 5 | 2012 | 55 | 0.340 |
Why?
|
Coronavirus Infections | 3 | 2023 | 3130 | 0.320 |
Why?
|
Plasmodium berghei | 3 | 2015 | 168 | 0.320 |
Why?
|
Antigens, Protozoan | 4 | 2021 | 322 | 0.320 |
Why?
|
Merozoite Surface Protein 1 | 3 | 2021 | 38 | 0.310 |
Why?
|
Genome, Bacterial | 2 | 2024 | 754 | 0.310 |
Why?
|
Male | 66 | 2023 | 349538 | 0.300 |
Why?
|
Proguanil | 1 | 2006 | 11 | 0.290 |
Why?
|
Female | 64 | 2024 | 379592 | 0.290 |
Why?
|
Seroepidemiologic Studies | 3 | 2024 | 402 | 0.290 |
Why?
|
Cytochromes b | 1 | 2006 | 36 | 0.290 |
Why?
|
Microbial Sensitivity Tests | 2 | 2024 | 1871 | 0.290 |
Why?
|
Sierra Leone | 8 | 2020 | 166 | 0.280 |
Why?
|
Parasitic Sensitivity Tests | 3 | 2012 | 83 | 0.280 |
Why?
|
Rifampin | 2 | 2021 | 315 | 0.280 |
Why?
|
Naphthoquinones | 1 | 2006 | 77 | 0.280 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2021 | 171 | 0.280 |
Why?
|
Communicable Diseases | 1 | 2014 | 878 | 0.270 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2020 | 880 | 0.270 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2024 | 130 | 0.270 |
Why?
|
Sequence Analysis, DNA | 8 | 2021 | 4801 | 0.270 |
Why?
|
Genotype | 8 | 2023 | 12946 | 0.260 |
Why?
|
Hepatitis B virus | 3 | 2023 | 513 | 0.260 |
Why?
|
Murinae | 2 | 2022 | 18 | 0.250 |
Why?
|
Hemorrhagic Fevers, Viral | 2 | 2016 | 24 | 0.250 |
Why?
|
Point Mutation | 2 | 2006 | 1624 | 0.240 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2020 | 602 | 0.240 |
Why?
|
Endemic Diseases | 3 | 2017 | 182 | 0.240 |
Why?
|
Multilocus Sequence Typing | 1 | 2024 | 99 | 0.240 |
Why?
|
HIV-1 | 1 | 2022 | 6934 | 0.240 |
Why?
|
Communicable Diseases, Emerging | 2 | 2018 | 156 | 0.230 |
Why?
|
Cross Reactions | 3 | 2020 | 841 | 0.230 |
Why?
|
Animals, Domestic | 1 | 2023 | 56 | 0.230 |
Why?
|
Area Under Curve | 6 | 2017 | 1653 | 0.230 |
Why?
|
Saliva | 3 | 2013 | 805 | 0.230 |
Why?
|
Swine | 2 | 2024 | 5934 | 0.230 |
Why?
|
Goats | 1 | 2023 | 172 | 0.230 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4554 | 0.220 |
Why?
|
Disease Reservoirs | 3 | 2018 | 131 | 0.220 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2004 | 224 | 0.220 |
Why?
|
Adolescent | 23 | 2021 | 85649 | 0.210 |
Why?
|
Capreomycin | 1 | 2021 | 14 | 0.210 |
Why?
|
Democratic Republic of the Congo | 2 | 2019 | 88 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3585 | 0.200 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1792 | 0.200 |
Why?
|
Environmental Microbiology | 1 | 2021 | 46 | 0.200 |
Why?
|
Ciprofloxacin | 2 | 2015 | 314 | 0.200 |
Why?
|
Mammals | 2 | 2024 | 1135 | 0.190 |
Why?
|
Phylogeography | 2 | 2018 | 81 | 0.190 |
Why?
|
Liberia | 2 | 2023 | 167 | 0.190 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2011 | 0.190 |
Why?
|
Antibodies, Neutralizing | 2 | 2024 | 1970 | 0.190 |
Why?
|
Vesiculovirus | 1 | 2020 | 50 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2022 | 181 | 0.180 |
Why?
|
Chlorpheniramine | 3 | 2008 | 13 | 0.180 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 194 | 0.180 |
Why?
|
Sulfalene | 3 | 2008 | 3 | 0.170 |
Why?
|
Fluoroquinolones | 1 | 2021 | 308 | 0.170 |
Why?
|
Treatment Outcome | 24 | 2021 | 62966 | 0.170 |
Why?
|
Blood | 3 | 2010 | 598 | 0.170 |
Why?
|
Viral Envelope Proteins | 2 | 2020 | 635 | 0.170 |
Why?
|
Ritonavir | 1 | 2021 | 322 | 0.170 |
Why?
|
Histamine H1 Antagonists | 3 | 2008 | 100 | 0.170 |
Why?
|
Africa South of the Sahara | 5 | 2022 | 724 | 0.170 |
Why?
|
Dogs | 1 | 2024 | 3910 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2012 | 5019 | 0.160 |
Why?
|
HIV Infections | 2 | 2022 | 16678 | 0.160 |
Why?
|
Haplorhini | 1 | 2019 | 551 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 15494 | 0.160 |
Why?
|
Administration, Oral | 5 | 2021 | 3913 | 0.160 |
Why?
|
Receptors, Virus | 1 | 2021 | 648 | 0.150 |
Why?
|
Cattle | 1 | 2024 | 3923 | 0.150 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4742 | 0.150 |
Why?
|
Plants, Medicinal | 2 | 2010 | 167 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2021 | 532 | 0.150 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.150 |
Why?
|
Drug Resistance, Viral | 1 | 2022 | 820 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2020 | 1003 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4438 | 0.140 |
Why?
|
DNA, Bacterial | 1 | 2021 | 1465 | 0.140 |
Why?
|
Sesquiterpenes | 2 | 2007 | 175 | 0.140 |
Why?
|
Biological Evolution | 3 | 2016 | 1074 | 0.130 |
Why?
|
Adult | 21 | 2023 | 213712 | 0.130 |
Why?
|
South Africa | 1 | 2021 | 1728 | 0.130 |
Why?
|
Alleles | 3 | 2012 | 6931 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 552 | 0.130 |
Why?
|
Vaccines | 1 | 2024 | 817 | 0.130 |
Why?
|
Markov Chains | 1 | 2018 | 969 | 0.130 |
Why?
|
Young Adult | 12 | 2023 | 56350 | 0.130 |
Why?
|
Filoviridae | 1 | 2014 | 16 | 0.130 |
Why?
|
Prevalence | 7 | 2022 | 15194 | 0.130 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4929 | 0.120 |
Why?
|
Plant Extracts | 2 | 2010 | 469 | 0.120 |
Why?
|
Promethazine | 3 | 2009 | 29 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.120 |
Why?
|
Inhibitory Concentration 50 | 2 | 2012 | 459 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 636 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 740 | 0.120 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.120 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 211 | 0.110 |
Why?
|
Thiazoles | 1 | 2021 | 1484 | 0.110 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1319 | 0.110 |
Why?
|
Mutation | 7 | 2023 | 29717 | 0.110 |
Why?
|
Population Surveillance | 2 | 2021 | 2616 | 0.110 |
Why?
|
DNA, Viral | 3 | 2023 | 2224 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3862 | 0.100 |
Why?
|
Aminoquinolines | 1 | 2012 | 109 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2020 | 1780 | 0.100 |
Why?
|
Child Health Services | 1 | 2017 | 667 | 0.100 |
Why?
|
Public Health | 1 | 2024 | 2594 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1472 | 0.090 |
Why?
|
Body Weight | 3 | 2012 | 4664 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2303 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2021 | 2978 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4420 | 0.090 |
Why?
|
Middle Aged | 11 | 2023 | 213127 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2020 | 3420 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2019 | 2026 | 0.090 |
Why?
|
Desiccation | 1 | 2009 | 70 | 0.090 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2010 | 768 | 0.090 |
Why?
|
Medicine, Traditional | 1 | 2010 | 91 | 0.090 |
Why?
|
Evolution, Molecular | 3 | 2014 | 1937 | 0.090 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2010 | 424 | 0.090 |
Why?
|
Specimen Handling | 2 | 2015 | 692 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2006 | 7873 | 0.080 |
Why?
|
Acute Disease | 4 | 2018 | 7141 | 0.080 |
Why?
|
Time Factors | 7 | 2021 | 40054 | 0.080 |
Why?
|
Proteins | 1 | 2004 | 6096 | 0.080 |
Why?
|
Disease | 1 | 2014 | 681 | 0.080 |
Why?
|
Arm | 1 | 2011 | 589 | 0.080 |
Why?
|
Multigene Family | 1 | 2012 | 1102 | 0.080 |
Why?
|
Herpes Labialis | 1 | 2008 | 29 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1967 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1251 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 24913 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 440 | 0.080 |
Why?
|
Brazil | 1 | 2012 | 1263 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2013 | 1574 | 0.080 |
Why?
|
Interleukins | 1 | 2012 | 791 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1548 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2015 | 10943 | 0.070 |
Why?
|
Orosomucoid | 1 | 2006 | 45 | 0.070 |
Why?
|
Plasmodium | 1 | 2010 | 248 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1661 | 0.070 |
Why?
|
Atovaquone | 1 | 2006 | 58 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39004 | 0.070 |
Why?
|
Hepatomegaly | 1 | 2006 | 85 | 0.070 |
Why?
|
Quinolines | 3 | 2018 | 719 | 0.070 |
Why?
|
Base Sequence | 2 | 2015 | 12797 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3518 | 0.070 |
Why?
|
Travel | 2 | 2017 | 788 | 0.070 |
Why?
|
Treatment Failure | 3 | 2012 | 2615 | 0.070 |
Why?
|
Guinea | 2 | 2016 | 41 | 0.070 |
Why?
|
Senegal | 1 | 2006 | 294 | 0.070 |
Why?
|
Amino Acid Sequence | 3 | 2020 | 13814 | 0.070 |
Why?
|
Rats | 1 | 2022 | 24265 | 0.070 |
Why?
|
Medicine, African Traditional | 1 | 2005 | 29 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 977 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7153 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2012 | 956 | 0.070 |
Why?
|
Malawi | 1 | 2006 | 281 | 0.070 |
Why?
|
Age Distribution | 1 | 2011 | 2900 | 0.070 |
Why?
|
Fever | 3 | 2024 | 1612 | 0.070 |
Why?
|
Databases as Topic | 1 | 2007 | 475 | 0.070 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.060 |
Why?
|
Risk Factors | 6 | 2017 | 72145 | 0.060 |
Why?
|
Codon | 1 | 2006 | 611 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2851 | 0.060 |
Why?
|
Recurrence | 2 | 2008 | 8333 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1372 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2015 | 21719 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14720 | 0.060 |
Why?
|
Genes, pol | 1 | 2023 | 51 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 1940 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6534 | 0.060 |
Why?
|
Program Evaluation | 1 | 2011 | 2485 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2004 | 587 | 0.050 |
Why?
|
Microscopy | 2 | 2008 | 903 | 0.050 |
Why?
|
Hepatitis B e Antigens | 1 | 2023 | 133 | 0.050 |
Why?
|
Immunoassay | 2 | 2018 | 752 | 0.050 |
Why?
|
Hepatitis B Antibodies | 1 | 2023 | 159 | 0.050 |
Why?
|
Herpesvirus 1, Human | 1 | 2008 | 742 | 0.050 |
Why?
|
Age Factors | 5 | 2014 | 18355 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2837 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2257 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 53187 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7645 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2023 | 305 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2572 | 0.050 |
Why?
|
Ribavirin | 2 | 2014 | 395 | 0.050 |
Why?
|
Drug Interactions | 3 | 2014 | 1458 | 0.050 |
Why?
|
Nitro Compounds | 1 | 2021 | 75 | 0.050 |
Why?
|
Half-Life | 2 | 2013 | 658 | 0.050 |
Why?
|
Genetic Markers | 1 | 2007 | 2633 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12220 | 0.050 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 468 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3306 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10163 | 0.050 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 1179 | 0.050 |
Why?
|
Survival Analysis | 4 | 2014 | 10248 | 0.050 |
Why?
|
Immune Sera | 1 | 2020 | 641 | 0.040 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 210 | 0.040 |
Why?
|
Survivors | 2 | 2020 | 2286 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19862 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6608 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.040 |
Why?
|
Verapamil | 2 | 2012 | 244 | 0.040 |
Why?
|
Viral Load | 2 | 2021 | 3292 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2051 | 0.040 |
Why?
|
Congo | 1 | 2018 | 13 | 0.040 |
Why?
|
Culicidae | 1 | 2019 | 104 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 229 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 2019 | 427 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4751 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15530 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 627 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18112 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 159 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 136 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2020 | 908 | 0.040 |
Why?
|
Proteinuria | 1 | 2020 | 657 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5948 | 0.040 |
Why?
|
Serologic Tests | 1 | 2019 | 374 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 652 | 0.040 |
Why?
|
Standard of Care | 1 | 2021 | 562 | 0.040 |
Why?
|
Arenavirus | 1 | 2016 | 7 | 0.040 |
Why?
|
Population Dynamics | 1 | 2018 | 301 | 0.040 |
Why?
|
Microfluidics | 1 | 2022 | 662 | 0.030 |
Why?
|
Climate | 1 | 2017 | 147 | 0.030 |
Why?
|
Virology | 1 | 2016 | 77 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2020 | 596 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1547 | 0.030 |
Why?
|
Gene Library | 1 | 2019 | 1076 | 0.030 |
Why?
|
Immunization | 1 | 2020 | 1255 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2019 | 572 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2479 | 0.030 |
Why?
|
Demography | 1 | 2020 | 1650 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2016 | 311 | 0.030 |
Why?
|
Geography | 1 | 2017 | 669 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2088 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2016 | 1094 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12071 | 0.030 |
Why?
|
Exanthema | 1 | 2018 | 488 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29087 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1348 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 854 | 0.030 |
Why?
|
Primate Diseases | 1 | 2012 | 15 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1538 | 0.030 |
Why?
|
England | 1 | 2014 | 523 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13403 | 0.030 |
Why?
|
Virus Diseases | 1 | 2019 | 710 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2016 | 1723 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2013 | 379 | 0.030 |
Why?
|
Bacterial Toxins | 1 | 2018 | 933 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1170 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2459 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 1526 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1175 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 632 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2014 | 337 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1002 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 63 | 0.020 |
Why?
|
Health | 1 | 2014 | 390 | 0.020 |
Why?
|
Incidence | 2 | 2023 | 20928 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3490 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2014 | 780 | 0.020 |
Why?
|
Hypoxanthine | 1 | 2010 | 28 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9941 | 0.020 |
Why?
|
Diamines | 1 | 2010 | 59 | 0.020 |
Why?
|
Primates | 1 | 2012 | 543 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3528 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2009 | 220 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1421 | 0.020 |
Why?
|
Tritium | 1 | 2010 | 746 | 0.020 |
Why?
|
Histamine Antagonists | 1 | 2009 | 93 | 0.020 |
Why?
|
Sickle Cell Trait | 2 | 1960 | 81 | 0.020 |
Why?
|
Erythrocytes, Abnormal | 2 | 1960 | 125 | 0.020 |
Why?
|
Epitopes | 1 | 2016 | 2569 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 77098 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 247 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2795 | 0.020 |
Why?
|
Community Medicine | 1 | 2008 | 25 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2450 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1020 | 0.020 |
Why?
|
Seasons | 1 | 2014 | 1492 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1059 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1899 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40450 | 0.020 |
Why?
|
Rural Population | 2 | 2008 | 2207 | 0.020 |
Why?
|
Common Cold | 1 | 2008 | 61 | 0.020 |
Why?
|
Patient Compliance | 2 | 2008 | 2680 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8297 | 0.020 |
Why?
|
Life Cycle Stages | 1 | 2008 | 160 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1343 | 0.020 |
Why?
|
Suppositories | 1 | 2007 | 15 | 0.020 |
Why?
|
Community Health Services | 1 | 2012 | 650 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2260 | 0.020 |
Why?
|
Desipramine | 1 | 2006 | 184 | 0.020 |
Why?
|
Artemia | 1 | 2005 | 5 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8621 | 0.020 |
Why?
|
Government Programs | 1 | 2008 | 275 | 0.020 |
Why?
|
Lethal Dose 50 | 1 | 2005 | 77 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5454 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1099 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 548 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 281 | 0.020 |
Why?
|
Methanol | 1 | 2005 | 85 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15056 | 0.020 |
Why?
|
Toxicity Tests | 1 | 2005 | 121 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9846 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12242 | 0.010 |
Why?
|
Focus Groups | 1 | 2008 | 1320 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5133 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 689 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2857 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1791 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13256 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 7901 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81045 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6365 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.010 |
Why?
|
Anemia, Sickle Cell | 2 | 1960 | 1017 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2699 | 0.010 |
Why?
|
Filariasis | 1 | 1961 | 28 | 0.010 |
Why?
|
Health Education | 1 | 2008 | 1053 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2536 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25575 | 0.010 |
Why?
|
Cameroon | 4 | 1961 | 70 | 0.010 |
Why?
|
Leishmaniasis | 1 | 1960 | 46 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5872 | 0.010 |
Why?
|
Qualitative Research | 1 | 2008 | 2680 | 0.010 |
Why?
|
Ulcer | 1 | 1960 | 209 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5062 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7790 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2008 | 2266 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1959 | 179 | 0.010 |
Why?
|
Aged | 2 | 2021 | 162944 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6452 | 0.010 |
Why?
|
Caregivers | 1 | 2008 | 2074 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3800 | 0.010 |
Why?
|
Internet | 1 | 2007 | 3062 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12773 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18006 | 0.010 |
Why?
|
Research | 1 | 1959 | 1999 | 0.010 |
Why?
|
United States | 1 | 2014 | 69693 | 0.000 |
Why?
|